Regenerative endodontics: barriers and strategies for clinical translation
- PMID: 22835543
- PMCID: PMC4093795
- DOI: 10.1016/j.cden.2012.05.005
Regenerative endodontics: barriers and strategies for clinical translation
Abstract
Regenerative endodontics has encountered substantial challenges toward clinical translation. The adoption by the American Dental Association of evoked pulp bleeding in immature permanent teeth is an important step for regenerative endodontics. However, there is no regenerative therapy for most endodontic diseases. Simple recapitulation of cell therapy and tissue engineering strategies that are under development for other organ systems has not led to clinical translation in regeneration endodontics. Recent work using novel biomaterial scaffolds and growth factors that orchestrate the homing of host endogenous cells represents a departure from traditional cell transplantation approaches and may accelerate clinical translation.
Copyright © 2012 Elsevier Inc. All rights reserved.
Conflict of interest statement
Columbia University is the owner of patents for several regenerative endodontic agents and methods on behalf of Dr. Jeremy Mao’s laboratory.
References
-
- Ingle JI, Slavkin HC. Modern Endodontic Therapy: Past, Present and Future. In: Ingle JI, Bakland LK, Baumgartner JC, editors. Ingle’s Endodontics. 6th edition. Hamilton: BC Decker Inc; 2008. pp. 1–35.
-
- Ng YL, Mann V, Rahbaran S, et al. Outcome of primary root canal treatment: systematic review of the literature - part 1. Effects of study characteristics on probability of success. Int Endod J. 2007;40(12):921–939. - PubMed
-
- Ng YL, Mann V, Gulabivala K. Outcome of secondary root canal treatment: a systematic review of the literature. Int Endod J. 2008;41(12):1026–1046. - PubMed
-
- American Dental Association. Changes to the code 2011–2012. Current dental terminology. 2010:89.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
